Javascript must be enabled to continue!
Severe Hepatic Encephalopathy after the Transjugular Intrahepatic Portosystemic Shunt
View through CrossRef
Aim. To demonstrate a case of severe hepatic encephalopathy with focal neurological symptoms in the early postoperative period after transjugular intrahepatic portosystemic shunting (TIPS).
Key points. TIPS is the most common and effective pathogenetically justified shunting method for correcting portal hypertension in liver cirrhosis. The modern transplantology doctrine dictates an increasing need for TIPS as a bridge technology that improves patient survival on the liver transplant waiting list. The progression of hepatic encephalopathy in the postoperative period following this intervention is the main expected adverse consequence of the procedure. Timely diagnosis of worsening neuropsychiatric function in patients who have undergone TIPS and its effective restoration are pressing issues in contemporary gastroenterological practice. Screening examinations to detect hepatic encephalopathy should be regularly performed for all patients, who have undergone TIPS, regardless of the timing of the procedure. Complex therapy, including ornithine, lactulose, and antibacterial drugs to suppress excessive bacterial growth in the intestine, should be prescribed from the first days after the intervention. Since suppressing excessive bacterial growth in the intestine in patients with hepatic encephalopathy is an independent pathogenetically based therapeutic target, cyclical use of antibacterial agents for intestinal sanitation in patients with TIPS significantly enhances the effectiveness of controlling hepatic encephalopathy.
Conclusion. This case clearly demonstrates that the foundation of successful treatment for a patient with liver cirrhosis lies in the continuity and interconnection of all stages of care provision.
Keywords: hepatic encephalopathy, transjugular intrahepatic portosystemic shunt, TIPS, portal hypertension, liver cirrhosis, liver transplant waiting list, excessive bacterial growth, cyclical bowel sanitation
NP Rusmedical Group
Title: Severe Hepatic Encephalopathy after the Transjugular Intrahepatic Portosystemic Shunt
Description:
Aim.
To demonstrate a case of severe hepatic encephalopathy with focal neurological symptoms in the early postoperative period after transjugular intrahepatic portosystemic shunting (TIPS).
Key points.
TIPS is the most common and effective pathogenetically justified shunting method for correcting portal hypertension in liver cirrhosis.
The modern transplantology doctrine dictates an increasing need for TIPS as a bridge technology that improves patient survival on the liver transplant waiting list.
The progression of hepatic encephalopathy in the postoperative period following this intervention is the main expected adverse consequence of the procedure.
Timely diagnosis of worsening neuropsychiatric function in patients who have undergone TIPS and its effective restoration are pressing issues in contemporary gastroenterological practice.
Screening examinations to detect hepatic encephalopathy should be regularly performed for all patients, who have undergone TIPS, regardless of the timing of the procedure.
Complex therapy, including ornithine, lactulose, and antibacterial drugs to suppress excessive bacterial growth in the intestine, should be prescribed from the first days after the intervention.
Since suppressing excessive bacterial growth in the intestine in patients with hepatic encephalopathy is an independent pathogenetically based therapeutic target, cyclical use of antibacterial agents for intestinal sanitation in patients with TIPS significantly enhances the effectiveness of controlling hepatic encephalopathy.
Conclusion.
This case clearly demonstrates that the foundation of successful treatment for a patient with liver cirrhosis lies in the continuity and interconnection of all stages of care provision.
Keywords: hepatic encephalopathy, transjugular intrahepatic portosystemic shunt, TIPS, portal hypertension, liver cirrhosis, liver transplant waiting list, excessive bacterial growth, cyclical bowel sanitation.
Related Results
Portosystemic shunt without surgery
Portosystemic shunt without surgery
Objective.
- To determine the effectiveness of the Palmaz balloon expandable stent for the creation of a transjugular intrahepatic portosystemic shunt. The device is de...
Congenital portosystemic shunts in dogs
Congenital portosystemic shunts in dogs
Congenital portosystemic shunt is one of the commonest congenital abnormalities in dogs. The objective of our study was to determine the presence of portosystemic shunts in the dog...
Portosystemic shunting procedures for complicated portal hypertension: modern opportunities of mini-invasive technique
Portosystemic shunting procedures for complicated portal hypertension: modern opportunities of mini-invasive technique
Aim. To improve the results of treatment for patients with complicated portal hypertension of cirrhotic genesis using the transjugular intahepatic portosystemic shunt with endovasc...
Innovation in direct intrahepatic portosystemic shunt; a developing country experience
Innovation in direct intrahepatic portosystemic shunt; a developing country experience
Anticoagulants are the first-line treatment option for patients with Budd-Chiari syndrome (BCS); however, intervention is required when this fails. Although, the ultimate treatment...
Reduced Serum Cholinesterase Activity Distinguishes Hepatic Encephalopathy From 48 Types of Human Diseases
Reduced Serum Cholinesterase Activity Distinguishes Hepatic Encephalopathy From 48 Types of Human Diseases
Abstract
Background: Hepatic encephalopathy is a complication of central nervous systems due to liver failure-related brain inflammation. Less than half of patients sufferi...
Minimal Hepatic Encephalopathy: The Reality Beyond Our Eyes
Minimal Hepatic Encephalopathy: The Reality Beyond Our Eyes
Introduction: Minimal hepatic encephalopathy refers to a mild neurocognitive impairment not detectable by clinical examination that can be present in cirrhotic patients.Aim: To det...
Transjugular Intrahepatic Portosystemic Shunt in Liver Transplant Recipients: Outcomes in Six Adult Patients
Transjugular Intrahepatic Portosystemic Shunt in Liver Transplant Recipients: Outcomes in Six Adult Patients
Objectives
Transjugular intrahepatic portosystemic shunt (TIPS) is regularly used in treatment of clinically significant portal hypertension. Liver transplant r...
Frequency of Recurrence of Hepatic Encephalopathy in Patients of Chronic Liver Disease Treated With Rifaximin
Frequency of Recurrence of Hepatic Encephalopathy in Patients of Chronic Liver Disease Treated With Rifaximin
Aim: To determine the frequency of recurrence of hepatic encephalopathy in patients treated with Rifaximin. Study design: Observational cross-sectional study. Setting & duratio...

